Professional Documents
Culture Documents
Ast2 JS01
Ast2 JS01
REAGENT
INTENDED USE
For the in vitro quantitative determination of Aspartate Aminotransferase (AST) in Bilirubin: No significant interference ( 10%) from bilirubin up to 22.7 mg/dL. PERFORMANCE
serum. Lipemia: No significant interference ( 10%) from lipemia up to 533 mg/dL Linearity:
measured as triglycerides. When run as recommended the assay is linear from 1.2 to 600 U/L.
SUMMARY AND EXPLANATION 1 2. See Young, et al.7or other interfering substances.
AST is widely distributed with high concentrations in the heart, liver, skeletal muscle, Method Comparison:
kidney and erythrocytes. Damage or disease to any of these tissues such as myocardial ADDITIONAL EQUIPMENT REQUIRED BUT NOT PROVIDED Studies performed between this procedure and a similar methodology yielded the
infarction, viral hepatitis, liver necrosis, cirrhosis and muscular dystrophy may result in 1. A clinical chemistry analyzer capable maintaining constant temperature (37°C) and following results:
raised serum levels of AST. measuring absorbance at 340nm. Number of samples pairs: 55
2. Deionized water and related equipment, e.g.: pipettes Range of samples: 12.0 – 278.0 (U/L)
METHODOLOGY 3. Analyzer specific consumables, e.g.: sample cups Correlation Coefficient: 0.9987
In 1955 Karmen2 developed a kinetic assay procedure for AST which was based upon the 4. Control material such as those provided by JAS Diagnostics. Slope: 0.9601
use of malate dehydrogenase and NADH. Henry3in 1960 and Amador and Wacker4 in Intercept: -4.1 (U/L)
1962 later presented optimized procedures. These modifications increased accuracy and ASSAY PROCEDURE
lowered the effect of interfering substances. The IFCC5 published a recommended These instructions are to be used as a general guideline for adapting to select automated Precision:
method that Included P-5-P in 1986. The present method is based on IFCC instruments. Refer to your specific JAS instrument application instructions available Within Run Level 1 Level 2 Level 3
recommendations but does not contain P-5-P, due that the diagnostic significance of AST upon request. Mean (U/L) 26.3 157.0 278.7
is under investigation S.D. (U/L) 0.7 0.5 1.0
SYSTEM PARAMETERS C.V. (%) 2.7 0.3 0.4
PRINCIPLE AST Total
AST Temperature: 37°C S.D. (U/L) 1.0 1.4 3.3
L-Aspartate + 2-Oxoglutarate Oxaloacetate +L- Glutamate Wavelength: 340 nm C.V. (%) 3.6 0.9 1.2
Assay Type: Rate/Kinetic
MDH Direction: Decrease Sensitivity:
Oxaloacetate+NADH L-Malate + NAD Sample / Rgt Ratio: 1: 10 The sensitivity for this reagent when run as recommended is 0.245 mA / min per
e.g. Sample Vol. 0.10mL (100L) U/L.
Aspartate aminotransferase (AST) catalyzes the transfer of the amino group from L- Reagent Vol. 1.0 mL
aspartate to 2-oxoglutarate to yield oxalacetate and L-glutamate. The oxaloacetate Delay/Lag Time: 30 Sec Note:Performance established on the Synchron CX.
undergoes reduction with simultaneous oxidation of NADH to NAD in the malate Read Time: 1-3 Min
dehydrogenase (MDH) catalyzed indicator reaction. The resulting rate of decrease in
absorbance at 340nm is directly proportional to the AST activity. Lactate dehydrogenase PROCEDURE NOTES REFERENCES
(LDH) is added to prevent interference from endogenous pyruvate which is normally 1. Samples with values above 600 U/L should be diluted 1:1 with saline, re-assayed 1. Zilva JF, Pannall PR: Plasma Enzymes in Diagnosis in Clinical Chemistry in
present in serum. and the results multiplied by two. Diagnosis and Treatment. Lloyd-Luke London.1979: Chap15:338-9
2. Karmen, A., et al, J. Clin, Invest. 34:126 (1955).
REAGENT COMPOSITION CALCULATION 3. Henry, R.J. et al, Am.J. Clin. Path. 34:381(1960).
Active Ingredients Concentrations One Unit (U/L) is defined as the amount of enzyme that catalyzes the transformation of 4. Amador, E., Wacker, W., Clin. Chem. 8:343 (1962).
2-Oxoglutarate 13 mM one micromole of substrate per minute under specified conditions. For example: 5. Expert Panel of Enzymes of the International Federation of Clinical Chemistry, Clin
L-Aspartate 220 mM
.Chem. 24: 497-510 (1986).
NADH >0.12 mM AST (U/L) = Abs. /min x 1.10 x 1000 =Abs/min x1768 6. Henry, R.J., Clinical Chemistry: Principles and Technics, 2nd Edition, Hagerstown
LDH (microbial) >1500 U/L 6.22 x 0.l0 x 1.0 (MD), Harper & Row, p. 882 (1974).
MDH (microbial) >100 U/L Where 7. Young, D.S., et al, Clin. Chem, 21:1D (1975).
pH (7.6 – 8.1) Abs. /min. = Average absorbance change per minute 8. Tietz, N.W., Fundamentals of Clinical Chemistry, Philadelphia, W.B. Saunders, p.
1.10 = Total reaction volume (ml) 682 (1976).
PRECAUTIONS 1000 = Conversion of U/mL to U/L
This reagent is for in vitro diagnostic use only. 6.22 = Millimolar absorptivity of NADH
0.10 = Sample Volume (mL)
REAGENT PREPARATION 1.0 = Light path in cm JAS Diagnostics, Inc.
Reagent is supplied ready to use.
7220 NW 58th St., Miami Florida 33166
Example: Tel. 305.418.2320 Fax. 305.418.2321
REAGENT STORAGE If the average absorbance change per minute = 0.12 Then 0.12 x 1768 = 212 U/L www.jasdiagnostics.com
1. Store the reagent at 2-8°C.
2. The reagent is stable until the expiration date when stored at 2-8°C. NOTES:
1. To convert to nkat/L multiply U/L by 16.67. Obelis (O.E.A.R.C.) “European Authorized Representative”
REAGENT DETERIORATION 2. If any of the test parameters are altered, a new factor must be calculated using the Avenue de Tervuren, 34 box 44 1040 Brussels
DO NOT USE REAGENT IF: above formula. Tel.: +32.2.732.59.54 Fax: +32.2.732.60.03
1. The initial absorbance, read against water at 340nm, is below 1.000.
Email: mail@obelis.net
2. The reagent fails to meet stated parameters of performance. CALIBRATION
The procedure is standardized by means of the millimolar absorptivity of NADH taken as
SPECIMEN COLLECTION AND HANDLING6 6.22 at 340nm under the test conditions described.
1. Non-hemolyzed serum is recommended. Red blood cells contain AST.
2. AST in serum is reported stable for seven days when refrigerated, one month frozen, QUALITY CONTROL
and three days when stored at room temperature. The integrity of the reaction should be monitored by use of a two level control with
known values such as JAS Chemistry Controls (P/N: CON1-5 and CON2-5)
INTERFERENCE
1. Studies to determine the level of interference for hemoglobin, bilirubin, and EXPECTED RANGE 8
lipemia were carried out, the following results were obtained: 5-34 U/L (37°C)
Hemoglobin: Use non-hemolyzed serum, as red blood cells contain AST. No It is strongly recommended that each laboratory establish its own reference range.
significant interference ( 10%) from hemoglobin up to 400 mg/dL